News & Trends - Pharmaceuticals
Transparency at a new level with MA’s centralised reporting system

Medicines Australia is pleased to announce the launch of a Centralised Reporting System available at www.DisclosureAustralia.com.au
The system will make it simpler than ever to understand interactions between pharmaceutical companies and healthcare professionals.
The system went live on Friday 30 August 2019 and will contain all information that was previously available through an individual company’s website, in an easily searchable form.
Medicines Australia CEO, Elizabeth de Somer thanked member companies for their support of the initiative.
“The Code of Conduct is already one of the best forms of a self-regulatory practice here in Australia, and has been since it was introduced almost 60 years ago,” said Ms de Somer.
“We are taking our already rigorous transparency model to the next level by providing a platform that’s easy to use and accessible to all.
“We are proud of the important role we play in educating medical professionals about the latest in innovative therapies.
“Our members provide clear information about payments to a healthcare professional so they can access the latest educational opportunities, attend conferences or symposia, or for their services as an expert.
“By supporting ongoing education, companies can assist healthcare professionals to acquire the appropriate understanding and knowledge of new innovative therapies, which is appropriate and accountable,” concluded Ms de Somer.
News & Trends - Biotechnology

CSL reshapes R&D while bracing for U.S. tariffs
Australia’s largest biotech company CSL is streamlining its R&D operations to enhance efficiency amidst a rapidly evolving global landscape. The […]
MoreNews & Trends - MedTech & Diagnostics

Australia joins Medtronic trial in fight against resistant hypertension
Medtronic has launched an international clinical trial across Australia, the United States, and Europe to evaluate the feasibility of multi-organ […]
MoreNews & Trends - MedTech & Diagnostics

Medibank launches pharmacogenetic testing while government stalls on insurance discrimination ban
Medibank has become the first Australian health insurer to pay towards pharmacogenetic testing (PGx) for eligible customers on Extras cover. […]
MoreNews & Trends - Pharmaceuticals

Global pledge shifts visibility and action for patients with advanced breast cancer
Three breast cancer organisations have united internationally to demand that people living with metastatic breast cancer (MBC) are no longer […]
More